OTCMKTS:TEAR TearLab (TEAR) Stock Price, News & Analysis $0.06 0.00 (-1.86%) As of 07/9/2020 Add Compare Share Share Stock Analysis Stock Analysis About TearLab Stock (OTCMKTS:TEAR) Get TearLab alerts:Sign Up Key Stats Today's Range$0.06▼$0.0650-Day Range$0.06▼$0.0652-Week Range$0.02▼$0.22Volume20,200 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview TearLab Corporation is a medical-device company focused on diagnostic solutions for eye-care professionals. Its primary business has centered on testing tear-film chemistry to help evaluate patients with dry-eye disease and other conditions affecting the ocular surface. The company’s principal product was the TearLab Osmolarity System, a point-of-care platform designed to measure tear osmolarity from a small tear sample. The system combined a handheld reader with disposable test cards, providing clinicians with an objective measurement that could support the diagnosis and management of dry-eye disease. TearLab marketed its products through eye-care channels in the United States and internationally. The company was historically headquartered in San Diego, California, and its shares later traded over the counter under the symbol TEAR. Information about its current operations and leadership is limited.AI Generated. May Contain Errors. Read More Receive TEAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TearLab and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TEAR Stock News HeadlinesHarrow Announces New Appointments to its Board of DirectorsJanuary 29, 2024 | finance.yahoo.comSTRATA Skin Science Announces Leadership ChangeOctober 30, 2023 | benzinga.comManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 in one quarter. Institutions own about 83% of shares, including BlackRock's 32 million shares worth $716 million and Vanguard's 48 million shares worth nearly $1.1 billion. A new multi-year deal with Palantir adds an AI-driven edge to this energy producer's operations.September 28 at 1:00 AM | Monument Traders Alliance (Ad)Ocular Therapeutix™ Announces Appointment of New Board MemberJuly 12, 2023 | finance.yahoo.comOcular Allergy Diagnostic Systems Market Size 2023 with End-user Industries, Segments Covered in the ReportJanuary 15, 2023 | marketwatch.comHousing Authority officials want more police help at East AcresSeptember 9, 2022 | yahoo.comLawrence schools on 'good footing' financiallySeptember 9, 2022 | yahoo.comPathway Makes Four Senior PromotionsSeptember 9, 2022 | nz.finance.yahoo.comSee More Headlines TEAR Stock Analysis - Frequently Asked Questions How have TEAR shares performed this year? TearLab's stock was trading at $0.0579 on January 1st, 2026. Since then, TEAR shares have increased by 0.0% and is now trading at $0.0579. How were TearLab's earnings last quarter? TearLab Corporation (OTCMKTS:TEAR) released its quarterly earnings data on Thursday, August, 8th. The medical research company reported ($0.10) earnings per share for the quarter. The medical research company had revenue of $5.85 million for the quarter. When did TearLab's stock split? TearLab's stock reverse split before market open on Friday, February 24th 2017.The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 23rd 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of TearLab? Shares of TEAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of TearLab own? Based on aggregate information from My MarketBeat watchlists, some other companies that TearLab investors own include Protalix BioTherapeutics (PLX), SCYNEXIS (SCYX), CorMedix (CRMD) and Rigel Pharmaceuticals (RIGL). Company Calendar Last Earnings8/08/2019Today9/28/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:TEAR Previous SymbolNASDAQ:TEAR CIK1299139 Webwww.tearlab.com Phone858-455-6006Fax858-812-0540Employees34Year Founded2003Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:TEAR) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TearLab Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share TearLab With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
